The circadian clock gene period extends healthspan in aging Drosophila melanogaster - PubMed (original) (raw)
The circadian clock gene period extends healthspan in aging Drosophila melanogaster
Natraj Krishnan et al. Aging (Albany NY). 2009.
Abstract
There is increasing evidence that aging is affected by biological (circadian) clocks - the internal mechanisms that coordinate daily changes in gene expression, physiological functions and behavior with external day/night cycles. Recent data suggest that disruption of the mammalian circadian clock results in accelerated aging and increased age-related pathologies such as cancer; however, the links between loss of daily rhythms and aging are not understood. We sought to determine whether disruption of the circadian clock affects lifespan and healthspan in the model organism Drosophila melanogaster. We examined effects of a null mutation in the circadian clock gene period (per(01)) on the fly healthspan by challenging aging flies with short-term oxidative stress (24h hyperoxia) and investigating their response in terms of mortality hazard, levels of oxidative damage, and functional senescence. Exposure to 24h hyperoxia during middle age significantly shortened the life expectancy in per(01) but not in control flies. This homeostatic challenge also led to significantly higher accumulation of oxidative damage in per(01) flies compared to controls. In addition, aging per(01) flies showed accelerated functional decline, such as lower climbing ability and increased neuronal degeneration compared to age-matched controls. Together, these data suggest that impaired stress defense pathways may contribute to accelerated aging in the per mutant. In addition, we show that the expression of per gene declines in old wild type flies, suggesting that the circadian regulatory network becomes impaired with age.
Keywords: RING; longevity; neurodegeneration; oxidative stress.
Conflict of interest statement
The authors have no conflict of interests to declare.
Figures
Figure 1.
Lifespan of per01_and CSp_D. melanogaster in normoxia and following 24h hyperoxia at different ages (marked by arrow in B-D). (A) In normoxia, there was no significant difference in mean survival curves (p=0.23) (B) Hyperoxia on day 5 did not significantly affect longevity or survival curves (p=0.12) (C) Hyperoxia on day 20 resulted in a significant reduction (p<0.05) in average survival of _per01_flies compared to CSp with significant (p<0.0001) difference in survival curves. (D) Hyperoxia on day 35 resulted in more significant reduction (p<0.001) in average lifespan in _per01_flies compared to CSp and significant difference in survival curves (p<0.0001). Males with rescued per function (per01{per+}) treated with hyperoxia on day 35 had average lifespan similar to CSp but significantly different (p<0.001) from _per01_mutants.
Figure 2.
Oxidative damage accumulates to higher levels in aging _per01_flies. Fold increase was calculated based on day 5 values in CSp males under normoxia (numerical values are shown in Supplementary Table 2 and Supplementary Table 3). Top: Protein carbonyls (PC) in heads (A) and bodies (B) of CSp (solid line) and per01(broken line) in normoxia (black) and after hyperoxia (gray). PC levels were significantly higher in _per01_than in CSp fly heads on day 35 and 50, and on day 50 in bodies under normoxia. Hyperoxia on day 35 and 50 induced significantly higher PC levels _per01_head and bodies compared to CSp age-matched controls. Bottom: Lipid peroxidation product 4-HNE in heads (C) and bodies (D). In normoxia, _per01_flies accumulated significantly more 4-HNE in heads and bodies compared to CSp in all ages except day 5. Under hyperoxia, significant increase in 4-HNE accumulation was observed in _per01_heads and bodies on day 20, 35 and 50 compared to CSp males. For statistical analysis of PC and HNE data refer to Supplementary Table 2 and Supplementary Table 3.
Figure 3.
Vertical mobility deteriorates faster in _per01_flies, as demonstrated by the RING assay. Bars represent mean height climbed (with SEM) in CSp (open bars) and per01(black bars) males at indicated age. The climbing performance of _per01_males on day 5 was significantly higher (p<0.001) compared to CSp. With age, a rapid deterioration in climbing performance was noted in _per01_flies with mobility being significantly lower (* p<0.001) on day 20, 35, and 50 compared to age-matched CSp controls.
Figure 4.
Neuronal degeneration is accelerated in _per01_mutants compared to CSp and flies with restored per function (per01{per+}) on day 50. (A) Mean number of vacuoles (with SEM) representing neuronal degeneration was significantly higher in _per01_mutants compared with wild type CSp and flies with rescued per. Bars with different superscripts are significantly different at p<0.05, data based on 10-15 heads for each genotype. (B-D) Photomicrographs of representative brain sections of CSp, per01, and per01{per+} males. Arrows point to vacuolization.
Figure 5.
Expression of per mRNA declines with with age in heads of CSp flies.(A) Daily mRNA expression profiles of per in day 5, 35 and 50 male heads. White and black horizontal bars mark periods of light and darkness respectively. Values were normalized to rp49 and calibrated against ZT0 (taken as 1) for each age and represented as mean ± SEM of 3 bioreplicates. (B) The peak levels of per mRNA are significantly reduced (* = p<0.05) in 50 day old males compared to young control males. Values are mean ± SEM of 3 bioreplicates.
References
- Hastings MH, Reddy AB, Maywood ES. A clockwork web: Circadian timing in brain and periphery in health and disease. Nature Rev Neurosci. 2003;4:649–661. - PubMed
- Huang YL, Liu RY, Wang QS, Van Someren EJ, Xu H, Zhou JN. Age-associated difference in circadian sleep-wake and rest-activity rhythms. Physiol Behav. 2002;76:597–603. - PubMed
- Turek FW, Penev P, Zhang Y, van Reeth O, Zee P. Effects of age on the circadian system. Neurosci Biobehav Rev. 1995;19:53–58. - PubMed
- Hofman MA, Swaab DF. Living by the clock: the circadian pacemaker in older people. Ageing Res Rev. 2006;5:33–51. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- R01 GM073792/GM/NIGMS NIH HHS/United States
- R01 NS047663/NS/NINDS NIH HHS/United States
- NIH-NINDS NS047663/NS/NINDS NIH HHS/United States
- NIH-NIGMS GM073792/PHS HHS/United States
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases